首页> 外国专利> PHARMACEUTICAL COMPOSITION COMPRISING SHIZUKAOL B ISOLATED FORM EXTRACT OF CHLORANTHUS JAPONICUS WHICH PREVENTS AND TREATS ARTERIOSCLEROSIS OR INFLAMMATORY DISEASE BY INHIBITING EXPRESSION OF INTRACELLULAR ADHESION MOLECULE-1(ICAM-1) IN CELL

PHARMACEUTICAL COMPOSITION COMPRISING SHIZUKAOL B ISOLATED FORM EXTRACT OF CHLORANTHUS JAPONICUS WHICH PREVENTS AND TREATS ARTERIOSCLEROSIS OR INFLAMMATORY DISEASE BY INHIBITING EXPRESSION OF INTRACELLULAR ADHESION MOLECULE-1(ICAM-1) IN CELL

机译:包含Shizukaol B分离形式的日本梧桐的药物成分,通过抑制细胞内粘附分子1(ICAM-1)的表达来预防和治疗动脉硬化或炎症性疾病

摘要

PURPOSE: Provided is a pharmaceutical composition which comprises shizukaol B isolated from the extract of Chloranthus japonicus. The shizukaol B inhibits cell adhesion, in particular, the expression of intracellular adhesion molecule-1(ICAM-1) in a cell. Therefore, it prevents and treats arteriosclerosis or inflammatory diseases. CONSTITUTION: The pharmaceutical composition for prevention and treatment of arteriosclerosis or inflammatory diseases is characterized by containing, as an active ingredient, shizukaol B isolated from the extract of Chloranthus japonicus, wherein the shizukaol B is represented by the formula(1) and inhibits the expression of intracellular adhesion molecule-1(ICAM-1); and the inflammatory diseases includes rheumatoid arthritis, allergic asthma, osteoporosis and the like.
机译:用途:提供了一种药物组合物,其包含从日本花椰菜提取物中分离的紫苏酚B。 shizukaol B抑制细胞黏附,特别是抑制细胞内黏附分子-1(ICAM-1)的表达。因此,它预防和治疗动脉硬化或炎性疾病。组成:用于预防和治疗动脉硬化或炎性疾病的药物组合物,其特征在于,其包含从日本梧桐的提取物中分离得到的水izu酚B作为活性成分,其中所述水izu酚B由式(1)表示并抑制其表达。细胞内粘附分子-1(ICAM-1)的表达;炎性疾病包括类风湿性关节炎,过敏性哮喘,骨质疏松症等。

著录项

相似文献

  • 专利
  • 外文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号